Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

BTS-73947: new D1/D5 antagonist from Knoll

Aug. 16, 1996

Roche profiles pharmacokinetics, pharmacodynamics of new benzodiazepine

Aug. 16, 1996

first clinical study results reported for Ro-48-6791

Aug. 16, 1996

LY-23728, 5-HT2B antagonist reported by Lilly

Aug. 16, 1996

5-HT2 receptor ligands reported by Allelix

Aug. 16, 1996

Histamine H3 agonist increases slow-wave sleep in rats

Aug. 16, 1996

VML-251 phase IIa results reported

Aug. 16, 1996

Ono claims PGE2 agonists and antagonists

Aug. 16, 1996

Pain found to trigger unique pattern of brain responses

Aug. 16, 1996

Takeda seeks German approval for idebenone

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...